Wayne State University Hematology and Medical Oncology

Topics

• Multiple Myeloma Research and Treatments 136
• Acute Myeloid Leukemia Research 101
• Pancreatic and Hepatic Oncology Research 85
• Hematopoietic Stem Cell Transplantation 82
• Lymphoma Diagnosis and Treatment 59
• Chronic Myeloid Leukemia Treatments 56
• Prostate Cancer Treatment and Research 56
• CAR-T cell therapy research 55
• Cancer Immunotherapy and Biomarkers 50
• Medical Imaging Techniques and Applications 45
• Renal cell carcinoma treatment 40
• Chronic Lymphocytic Leukemia Research 37

Most cited

1. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.

   Lancet (London, England) · 2021 · 1,514 citations · Abinhav Deol

2. Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 554 citations · Abinhav Deol

3. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.

   The New England journal of medicine · 2021 · 562 citations · Jeffrey Zonder

4. Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.

   Blood · 2023 · 409 citations · Abinhav Deol

5. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 270 citations · Mark Zalupski

6. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

   The New England journal of medicine · 2022 · 422 citations ·